A safe means of anaesthetizing common marmosets (Callithrix iacchus) for a study using magnetic resonance imaging [MRI) to investigate cerebral ischaemia was required. Continuous infusion of alphaxalone/alphadalone was used to anaesthetize 37 marmosets for non-recovery and recovery experiments. This was found to give safe, reliable anaesthesia when coupled with pulse oximetry and electrocardiographic (ECG) monitoring.
marmoset
To study the effects of cerebral ischaemia and its development, photothrombotic lesions in non-recovery marmosets were visualized for 7-8h after lesion induction using MRI (the results of these experiments have been reported by James et a1. (1996) . Magnetic resonance imaging requires that all anaesthetic and monitoring equipment are either non-magnetic or are kept outside the Faraday cage surrounding the magnet (Holshouser et 01. 1993) . Each MRI sequence takes up to 30 min, so the ideal anaesthetic regimen should be simple, reliable and safe, and preclude rapid changes in anaesthetic depth. However the ability to modulate the level of anaesthesia is also required in case of anaesthetic under or overdosage. Phillips and Grist (1975) described the use of Saffan (Mallinckrodt Veterinary Ltd, Middlesex, UK), a mixture of the steroids alphaxalone and alphadalone (9 and 3 mg/ml respectively) solubilized in 20% polyoxyethylated castor oil in saline, for anaesthesia of the common marmoset. They
Correspondence to: G Whelan Accepted 2 March 1998 reported that a single intramuscular dose of 18mg/kg total steroid provided safe, reliable anaesthesia. Incremental intravenous (i.v.) doses can also be given to prolong anaesthesia safely (Green 1979) as neither tolerance nor accumulation occurs. Cookson and Mills (1983) also described continuous infusion anaesthesia of baboons with Saffan. Our previous experience with intravenous bolus injection of Saffan indicated that rapid deepening of anaesthesia could be achieved when necessary.
Gaseous anaesthesia was considered for these studies, but was not used due to the lack of an adequate waste gas scavenging system and the risk of rapid recovery in the event of accidental disconnection. Continuous infusion of propofol was also considered unsuitable due to questions over the adequacy of analgesia it provides for surgical procedures and rapid recovery times risking the return of consciousness in the event of accidental disconnection (FlecknellI996). Pentobarbitone was not considered suitable due to concerns over the adequacy of analgesia for the surgical procedure and the safety margin. Other drug combinations were considered, but it was decided that a singleagent regimen was preferred to reduce the possible interactions with the drug study being performed.
A number of anaesthetic agents are neuroprotective (see Stamford and Strunin 1996 for reviewL but the authors could find no specific data on the possible neuroprotective effects of Saffan. In the studies described below there was a control group, so any neuroprotective effects would be compensated for in the analysis of the results. It was decided that Saffan could give the greatest margin of anaesthetic safety without interc fering with the experimental objectives. The authors could find no published protocol for continuous infusion of Saffan in the common marmoset, so a suitable protocol was developed for these (non-recovery) MRI studies. We also present results from a follow-up recovery study.
Study 1 (Non-recovery experiment)

Materials and Methods
Twenty-two marmosets (11 male and 11 female, 320-'520gl, age range 2-5 years, bred in house and of conventional health status were used. They were housed in male:fema1e pairs (males had previously been vasectomized) in cages measuring 180cm x 81cm x 75em (height x depth x breadth) and fed on a pelleted diet (Marex, SDS, UKl, fresh fruit, bread, egg and vitamin D3 supplement with fresh water available ad libitum. All animals were either naive, or had been trained for behavioural studies (no drugs administered). Room temperature was 25°C, with a 12h light:dark cycle and 15 air changes per hour. Procedures were performed in compliance with the UK Animals (Scientific Proceduresl Act 1986, and the protocol was additionally subjected to local peer review. All animals were subjected to a veterinary examination prior to the study to confirm good health and body condition.
These animals were used in imaging experiments lasting up to 9.5h. Anaesthesia was induced with 15mg/kg total steroid· administered intramuscularly in divided doses into the left and right quadriceps femoris; typical total volumes were 0.4-0.7 ml of undiluted Saffan. Once a surgical plane of anaesthesia was reached the trachea was intubated as described by Morris et al. (1997) and secured using a 2.5 mm paediatric endotracheal tube holder (Portex, UK). This was then connected to a volume cycled ventilator (Harvard Rodent Ventilator, Harvard Apparatus Ltd, MA, USAl and ventilated with a 50:50 mixture of oxygen and medical air at a rate of 60 breaths per minute and stroke volume of approximately 5 ml. Successful endotracheal intubation was confirmed by looking for respiratory condensates on a polished surface held close to the tube exit. The tidal volume was adjusted to produce an arterial oxygen saturation of greater than 98% as confirmed by pulse oximetry (model 7840, Kontron, UKI.
To allow intravenous Saffan infusion, the tail was shaved and warmed (to dilate the lateral veins) for approximately one minute by placing it in a beaker of hand-hot water. The lateral tail vein was cannulated using a 23 gauge over-the-needle catheter (Vygonl, securely taped into place with micro pore tape (3M), and connected via a male:male connector to a 10m length of 0.32mm internal diameter polyethylene tubing (Portex) with 23 gauge needles inserted firmly into the lumen at each end. This tubing was pre-filled with Saffan prior to the commencement of the study. The second lateral tail vein was also cannulated for fluids and experimental drugs to be administered.
An infusion pump (Secura FT, Braun, Germany) with a 50ml syringe was used to infuse the Saffan. Prior to the study the pump was tested and was found to deliver volumes as low as 1ml/h with an accuracy of greater than 95%. The initial infusion rate was set at 36mg total steroid per kg body weight/h (at a rate of 3ml/kg/h) (P. A. Flecknell, personal communication) . The Saffan was administered undiluted.
Heart rate and ECG monitoring were performed using two copper electrodes, placed subcutaneously via a stab incision in to the left inguinal and right brachial regions and secured with tape. This was displayed on an oscilloscope, and checks were made approximately every 15 min for the presence of cardiac arrhythmias, and heart rate was recorded. When the animal was removed from the magnet after each of three imaging sessions, the pulse oximeter was applied to the hind foot to monitor the adequacy of oxygen saturation. This was only monitored intermittently as a standard pulse oximeter cannot be used in the MRI environment. If saturation fell below 98%, the ventilation rate was increased.
Normothermia (36-37°C) was maintained by a thermostatically-controlled blanket (Harvard Apparatus Inc, MA, USAl using a rectal probe to monitor temperature.
Briefly, surgery consisted of an incision in the scalp, then application of a cold, point light source to the skull over the frontal cortex whilst a photo-active dye (Rose Bengal) was administered intravenously via the previously placed tail vein cannula. This produced an ischaemic region in the brain of approximately 26mm
3 , compared to a total brain volume of approximately 7500mm 3 .
During surgery, preparation for imaging, and between imaging sessions, the animal was monitored for the depth of anaesthesia at frequent intervals. This involved checking pedal withdrawal reflexes, muscle tone and heart rate. The ideal depth was defined as absence of pedal withdrawal reflexes and muscle tone and a stable heart rate. If the heart rate varied from the steady-state the animal was examined for presence of muscle tone and pedal withdrawal reflex (suspending imaging and examining within the magnet if required). If a slight return of muscle tone or pedal withdrawal with an increase in heart rate occurred, the infusion rate was increased by approximately 25%, or if extremely light, a bolus of approximately 3mg was administered. A slowing of the heart rate in the absence of pedal withdrawal reflexes was regarded as being anaesthetic overdosage, and the infusion rate was reduced by 10% to 50% depending on the degree of bradycardia.
The animal was not placed in the MRI magnet until the anaesthetist was satisfied steady-state anaesthesia had been reached. Whilst in the magnet, the ECG was monitored at approximately 15 min intervals. All heart rates, drug administrations, and sig-
nificant events (e.g. time of surgery I were recorded on a standard record sheet during the procedure.
As infusion rates were supplying fluids at less than maintenance rates, and to replace fluids lost due to the desiccating effects of ventilation with non-humidified gases, 5ml of 5% glucose saline was administered by slow intravenous injection (over a lOmin period) after approximately 4 h of anaesthesia.
At the conclusion of the study, the marmoset was euthanized with an overdose of pentobarbitone (Euthetal, Rhone-Merieux, Essex, UKI, the brain was taken for histological measurement of lesion volume and compared to the lesions measured by MRL
Results
The intramuscular induction dose resulted in all animals reaching surgical anaesthesia rapidly. Anaesthesia lasted for between 6 and 9.5h. The average steady-state infusion rate was 27.7 mg (2.3ml)/kg/h (range 21.5mg to 44.6mg/kg/h) total steroids for females and 25mg (2.1ml)/kg/h (range 12.3 mg to 35.3 mg/kg/h) for males. There was no obvious change in the required infusion rates over the duration of the anaesthetic.
Four animals required intravenous bolus doses. These were early on in the study, and as experience with the regimen developed, no further bolus doses were required.
Heart rates during stable anaesthesia were between 180 and 300 beats per minute (BPM), varying between animals. On a few occasions tachycardia was observed in the absence of withdrawal reflexes. These cases occurred later on in the study and fluid administration reduced the heart rate to steady-state levels.
The second animal anaesthetized in this study became tachycardic and had a brisk pedal withdrawal reflex. This was found to be due to loss of the cannula in the lateral tail vein, and once replaced, stable anaesthesia resulted.
One animal was lost to the study due to non-anaesthetic related causes.
A second animal died under anaesthesia, after intubation and during the stabilization period. The ECG monitor had failed, and a replacement was being sought. The infusion rate was increased early on as the pedal withdrawal reflex started to return, but was not reduced as there was no indication from the pulse oximetry that the cardiovascular system was compromised (the monitor was unable to display marmoset heart rates). The marmoset died shortly before the start of surgery. A full necropsy was performed, but this showed no gross pathological changes (histological investigation was not performed).
Oxygen saturation was always greater than 95%, and was usually maintained between 98% and 100%
Study 2 (Recovery experiment)
This study was of a shorter duration, recovery procedure that also involved the production of a focal ischaemic lesion, treatment with experimental neuroprotective compounds and recovery for up to 7 days. No MRI or repeat anaesthesias were performed in this study (Milkowski et a1. 1994 ).
Materials and methods
Fifteen female marmosets (337-405 g, age range 2-5 years, supplied by the CBDE, Porton Down, UKl of conventional health status were used. They were maintained under husbandry conditions as described in Study 1. Anaesthesia was induced and maintained using the methods described in Study 1 (including ventilation). Surgery was also performed as described for Study l.
Electrocardiogram was not monitored in this study, but continuous (rather than the intermittent monitoring performed in Study 1) pulse oximetry was performed using a Nonin 8600FOfibre-optic pulse oximeter (CardioKinetics Ltd, Salford, UKI with a paediatric finger probe attached to a shaved hind foot. This gave continuous oxygen saturation and heart rate data. Anaesthesia and surgery lasted between 1.5 to 2.5 h (depending on the time required to prepare the animal). Anaesthesia was maintained at a surgical level (pedal withdrawal reflex just absentl for the duration of the procedure by a constant infusion of Saffan in 10 animals using the infusion system described for Study 1. In a further five animals, owing to technical difficulties, only one intravenous catheter was placed and anaesthesia was maintained by intermittent bolus injections of 24 mg. Boluses were administered as the pedal withdrawal reflex and muscle tone in the hind limb began to return.
After the infusion was stopped, the animal was placed in a recovery cage under a thermostatically-controlled heat lamp at 32°C, and the time taken from stopping infusion (or the end of the study when bolus administration was used) to the return of the righting reflex was recorded. Each marmoset was monitored constantly until sufficiently recovered to be returned to its home cage. This was considered to be when the marmoset could confidently walk and climb in the restricted confines of the recovery cage. Any excitement or other adverse signs shown in the recovery period were recorded. Postsurgical analgesia was provided by infiltration of the wound with mepivacaine (Intraepicaine, Arnolds, UK). Adequacy was assessed at intervals by gentle palpation of the wound and by observation of any interference with the wound.
The surgery produced measurable behavioural effects, without significantly affecting the marmosets' eating, grooming and locomotor behaviours. The purpose of the study was to compare the effects of treatments on these behaviours (unpublished data). At the conclusion of the study, the marmoset was euthanized with an overdose of pentobarbitone (Euthetal, Rhone-Merieux, Essex, UK), and the brain was taken for histological confirmation of lesion volume and position.
Results
Recovery in the animals anaesthetized by continuous infusion lasted a mean of 1.35h (range 0.75 to 2.25h). However recovery in the bolus maintained animals lasted a mean of 0.62h (range 0.25 to 1h). The quality of recovery was generally good, and was characterized by a gradual awakening accompanied by gentle shivering. Animals were generally fully recovered by 3h, with no obvious adverse effects.
Oxygen saturation was maintained between 98% and 100% for the duration of this study.
Discussion
Performing anaesthesia in the MRI environment is extremely challenging, as demonstrated by the problems faced during the early stages of Study 1. The use of standard monitoring equipment can be problematical in studies such as this. Many monitors, such as the pulse oximeter used in Study 1 cannot function in close proximity to the high magnetic fields used in MRI. The second study showed that the Nonin fibre-optic pulse oximeter (which is designed specifically for use in MRI) can be reliably used to constantly monitor the heart rate and oxygen saturation of the anaesthetized marmoset. This would provide further valuable information for the maintenance of safe anaesthesia.
Although the death in Study 1 was not confirmed to be due to anaesthetic overdose, in other animals anaesthetized with this regimen a decrease in heart rate was always consistent with deep anaesthesia. In these instances, reducing the infusion rate produced a rise in heart rate. It is likely that given the high infusion rate administered, and the lack of monitoring of heart rate that this animal died from anaesthetic overdose causing cardiac failure. This further emphasizes the need for reliable monitoring equipment.
The loss of the infusion cannula that occurred in Study 1 further demonstrates that the careful physiological monitoring and regular assessment of anaesthetic depth are essential. This problem was discovered before the return of consciousness, demonstrating clearly the advantage of having a relatively (compared to isoflurane and propofol) slow recovery period when working in a difficult situation where accidental discontinuation is a possibility.
In Study 2, the longer recovery times associated with continuous infusion as compared with bolus injections were likely to be caused by the continuation of infusion up to the end of the experiment. The time of the last bolus injection is not available, but it is likely that the recovery period from this last administration to the return of the righting reflex is similar to that of continuously infused animals. As experience is amassed using this regimen, the infusion could be reduced or even discontinued before the end of the experiment to reduce recovery times. Given the non-cumulative nature of Saffan, it is likely that longer periods of anaesthesia will result in similar recovery times, given the maintenance of normal body temperature and fluid balance.
Anaesthetic depth changed slowly and predictably, but could be deepened rapidly by intravenous bolus injections if necessary. Overdosage was characterized by a fall in heart rate, which was usually obvious before cardiac failure occurred. This margin of safety may not be as great in spontaneously breathing animals, as the ventilation may have been preventing respiratory failure. In such animals the respiratory system should be closely monitored by the use of such techniques as pulse oximetry, capnography or blood gas analysis.
Both the studies demonstrated that Saffan coupled with endotracheal intubation and ventilation produces safe, easily controlled surgical anaesthesia suitable for procedures of long duration in the common marmoset. Artificial ventilation was used from the outset to prevent the hypoxia and hypercapnia associated with respiratory depression. This would also improve cardiovascular stability and help to maintain cardiac output (and therefore cerebral blood flow, which is essential for central nervous system studies such as this). As such, no information can be offered as to the effects of long-term infusions of Saffan on the respiratory system. The use of artificial ventilation may have improved the safety margin of this regimen, and given the relative ease of intubation and ventilation (Morris et a1. 1997) , this should be considered for all long-term anaesthesia in the marmoset.
